| 1122 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Investigation of Infectious DiseaseRisks Associated With a Nontransplant Anatomical Donation Center -Arizona, 2014 |
Marie A. de Perio, MD1, Bruce P. Bernard, MD1, Lisa J. |
| CDC | 0.465293 |
| safe work practices | 0.572347 |
| anatomical donation organizations | 0.579539 |
| hepatitis B virus | 0.458124 |
| anatomical donation industry | 0.561629 |
| Lisa J. Delaney | 0.502001 |
| Nontransplant anatomical centers | 0.59679 |
| MMWR Early Release | 0.503721 |
| Nicole J. Cohen | 0.50056 |
| potential occupational exposure | 0.515986 |
| Zoonotic Infectious Diseases | 0.508528 |
| infectious agents | 0.476007 |
| Arizona public health | 0.671135 |
| anatomical donation center | 0.591376 |
| HBV | 0.475316 |
| proper disinfection procedures | 0.487956 |
| contact mucous membranes | 0.493411 |
| personal protective equipment | 0.480767 |
| OSHA Bloodborne Pathogens | 0.507995 |
| public health officials | 0.67136 |
| human nontransplant | 0.476357 |
| M. tuberculosis | 0.598349 |
| United States process | 0.4955 |
| work practice controls | 0.487679 |
| center cost-free testing | 0.497412 |
|
| human immunodeficiency virus | 0.503563 |
| HCV | 0.469516 |
| M. tuberculosis infection | 0.513525 |
| potentially infectious materials | 0.546572 |
| Animal Medical Diagnostic | 0.484496 |
| infectious tissues | 0.475531 |
| MMWR website | 0.456563 |
| Occupational Safety | 0.491041 |
| considerably lower risk | 0.491081 |
| employee exposure | 0.458637 |
| infectious aerosols | 0.473828 |
| nontransplant anatomical materials | 0.955181 |
| nontransplant anatomical donation | 0.748686 |
| occupational exposure risk | 0.502355 |
| hepatitis C virus | 0.458065 |
| potential exposure | 0.462776 |
| Spill Response | 0.45659 |
| exposure control plan | 0.494888 |
| Non-Transplant Anatomical Donation | 0.557374 |
| U.S. Postal Service | 0.483557 |
| proper environmental controls | 0.493009 |
| Bruce P. Bernard | 0.498178 |
| Bloodborne Pathogens Standard | 0.586148 |
| Mycobacterium tuberculosis | 0.476988 |
|
CLICK HERE |
| 7429 |
Centers for Disease Control and Prevention |
Html |
en |
Iowa Asthma Follow Up Study - Veterans Health - Gulf War Studies |
CDC's National Center for Environmental Health (NCEH) has taken the lead for HHS in addressing the health concerns of veterans of the Vietnam War and the Gulf War, and NCEH is working with the Departments of Defense and Veterans Affairs to protect the health of our future military forces. |
| telephone survey participants | 0.466852 |
| baseline pulmonary function | 0.480149 |
| list Skip | 0.453998 |
| past smokers | 0.390201 |
| self-report | 0.329269 |
| illnesses | 0.318375 |
| current symptoms | 0.381273 |
| page options Skip | 0.538815 |
| subjects | 0.31655 |
| groups | 0.332457 |
| asthma | 0.501434 |
| lower baseline spirometry | 0.480915 |
|
| navigation Skip | 0.453148 |
| original Iowa study | 0.477271 |
| Gulf War veterans | 0.950511 |
| non-Gulf War veterans | 0.513715 |
| measure | 0.316699 |
| telephone survey | 0.682421 |
| smoking history | 0.384568 |
| lungs | 0.320879 |
| physical examination data | 0.472493 |
| bronchial hyperreactivity | 0.502859 |
| subset | 0.321624 |
|
CLICK HERE |
| 8731 |
Centers for Disease Control and Prevention |
Html |
en |
Announcements: Global Road Safety Week - May 6-12,2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| Safety Week efforts | 0.583776 |
| mmwrq@cdc.gov. | 0.577604 |
| accessible facilities | 0.567632 |
| endorsement | 0.531069 |
| United Nations | 0.573321 |
| Human Services | 0.62702 |
| assistive technology | 0.578827 |
| U.S. Department | 0.625002 |
| MMWR HTML versions | 0.618475 |
| pedestrian zones | 0.619486 |
| road signs | 0.588484 |
| electronic PDF version | 0.613703 |
| middle-income countries | 0.575849 |
| risk factors | 0.564766 |
| World Health Organization | 0.630378 |
| Additional information | 0.568098 |
| Contact GPO | 0.575046 |
| commercial sources | 0.565402 |
| current prices | 0.563736 |
| original paper copy | 0.616003 |
| General Assembly | 0.573256 |
| larger UN Decade | 0.567607 |
| pedestrian deaths | 0.626478 |
| vast majority | 0.569652 |
|
| speed bumps | 0.571507 |
| pedestrian injuries | 0.615742 |
| U.S. Government Printing | 0.619823 |
| original MMWR paper | 0.616468 |
| MMWR readers | 0.567721 |
| character translation | 0.562581 |
| global road deaths | 0.664466 |
| global problem | 0.578014 |
| reflective materials | 0.568162 |
| vehicle speeds | 0.569407 |
| format errors | 0.56182 |
| subject line | 0.577604 |
| global road safety | 0.961864 |
| pedestrians | 0.599138 |
| typeset documents | 0.565077 |
| trade names | 0.56544 |
| official text | 0.561919 |
| mass transit route | 0.621208 |
| road traffic injuries | 0.636609 |
| non-CDC sites | 0.564585 |
| pedestrian safety | 0.67833 |
| best practices | 0.568298 |
| electronic conversions | 0.560856 |
| pedestrian crossings | 0.620235 |
|
CLICK HERE |
| 9451 |
Centers for Disease Control and Prevention |
Html |
es |
Mejora del rendimiento del sistema de salud pública por medio de asociaciones multiorganizacionales. |
null |
| Scutchfield FD | 0.359078 |
| múltiples organizaciones | 0.347442 |
| salud pública | 0.933435 |
|
| Mays GP | 0.360711 |
| Estados Unidos | 0.420296 |
| altos costos | 0.347513 |
|
CLICK HERE |
| 11710 |
Centers for Disease Control and Prevention |
Html |
en |
Alcohol Involvement in Opioid Pain Reliever andBenzodiazepine Drug Abuse-Related Emergency Department Visits andDrug-Related Deaths - United States, 2010 |
Christopher M. Jones, PharmD1, Leonard J. Paulozzi, MD2, Karin A. |
| DAWN ME data | 0.547161 |
| benzodiazepine deaths | 0.57232 |
| OPR drug | 0.545762 |
| abuse–related ED visits | 0.787552 |
| United States | 0.623523 |
| OPR abuse–related ED | 0.591904 |
| Drug Administration | 0.544138 |
| ED visits | 0.991544 |
| alcohol consumption | 0.603555 |
| benzodiazepine ED visits | 0.655949 |
| national ED visits | 0.621294 |
| benzodiazepine visits | 0.57281 |
| prescription drug abuse | 0.579913 |
| alcohol involvement | 0.702533 |
| prescription drugs | 0.548071 |
| single-drug class deaths | 0.602889 |
| drug abuse-related ED | 0.620951 |
| Excessive alcohol consumption | 0.601837 |
| alcohol overdose | 0.569821 |
| OPR ED visits | 0.633684 |
| benzodiazepine drug-related deaths | 0.61956 |
| benzodiazepine single-drug class | 0.548036 |
| Drug Abuse Warning | 0.552709 |
| alcohol | 0.85075 |
|
| single-drug class ED | 0.590821 |
| alcohol-related visits | 0.561645 |
| illicit drugs | 0.544487 |
| hospital ED visits | 0.622648 |
| benzodiazepines | 0.668043 |
| drugs | 0.610099 |
| OPRs | 0.610711 |
| alcohol increases | 0.584314 |
| Christopher M. Jones | 0.573296 |
| class ED visits | 0.623767 |
| DAWN ED | 0.615133 |
| problematic alcohol | 0.569219 |
| drug related deaths | 0.580656 |
| single drug-class deaths | 0.571183 |
| abuse-related ED visits | 0.656696 |
| alcohol consumption level | 0.584622 |
| pharmaceutical overdose deaths | 0.571044 |
| drug abuse–related ED | 0.687137 |
| OPR deaths | 0.593359 |
| OPR visits | 0.578234 |
| drug-related deaths | 0.783779 |
| ED visit data | 0.579513 |
| benzodiazepine-related deaths | 0.556675 |
|
CLICK HERE |
| 11843 |
Centers for Disease Control and Prevention |
Html |
en |
Questions and Answers: Estimating the Future Number of Cases in the Ebola Epidemic—Liberia and Sierra Leone, 2014–2015 |
null |
| Ebola Epidemic—Liberia | 0.360263 |
| hospitals/Ebola Treatment Units | 0.312931 |
| future number | 0.350508 |
| Ebola Treatment Units | 0.753672 |
| cases | 0.582476 |
| earlier Ebola outbreaks | 0.445255 |
| Mortality Weekly Report | 0.391955 |
| safe burial practices | 0.308534 |
| available case counts | 0.328584 |
| Sierra Leone | 0.653251 |
| community setting | 0.360652 |
| actual cases | 0.215416 |
|
| Ebola cases | 0.466011 |
| current trends | 0.200213 |
| disease control methods | 0.321649 |
| actual reported beds-in-use | 0.353337 |
| underreported cases | 0.256869 |
| safe burials | 0.38927 |
| EbolaResponse modeling tool | 0.325216 |
| past outbreaks | 0.31932 |
| Ebola Treatment Unit | 0.484453 |
| underreporting correction factor | 0.336858 |
| disease transmission | 0.921936 |
|
CLICK HERE |
| 11878 |
Centers for Disease Control and Prevention |
Html |
en |
Influenza Outbreak in a Vaccinated Population - USS Ardent,February 2014 |
Theodore L. Aquino, DO1, Gary T. Brice, PhD2, Sherry Hayes, MPH3, Christopher A. |
| Center San Diego | 0.358092 |
| Preventive Medicine Unit | 0.432131 |
| Ardent crew member | 0.406064 |
| influenza vaccination policy | 0.525361 |
| San Diego County | 0.346564 |
| nasal swab specimens | 0.999545 |
| seasonal influenza vaccination | 0.517233 |
| San Diego | 0.849812 |
| independent duty corpsman | 0.436884 |
| ILI cases | 0.442786 |
| influenza A. Ultimately | 0.563326 |
| ILI case | 0.426458 |
| influenza vaccine | 0.627407 |
| ILI symptoms | 0.758156 |
| outbreak response | 0.361913 |
| Public Health Services | 0.439824 |
| rapid influenza testing | 0.776649 |
| U.S. Navy minesweeper | 0.380544 |
| local naval health | 0.342019 |
| immediate influenza testing | 0.538563 |
| U.S. Navy | 0.485998 |
| Health Research Center | 0.667209 |
| ship outbreak | 0.361256 |
| hemisphere influenza season | 0.518432 |
|
| influenza | 0.781739 |
| Diego Public Health | 0.447259 |
| Naval Health Research | 0.545673 |
| influenza outbreaks | 0.447659 |
| USS Ardent sailor | 0.374397 |
| H3N2 influenza outbreak | 0.644008 |
| shipboard medical provider | 0.339197 |
| Theodore L. Aquino | 0.444398 |
| crew members | 0.985698 |
| USS Ardent | 0.79934 |
| ILI patients | 0.565675 |
| higher-level Navy authorities | 0.351446 |
| initial rapid influenza | 0.561949 |
| influenza season | 0.55381 |
| USS Ardent crew | 0.505646 |
| San Diego Public | 0.447276 |
| ILI patient | 0.504075 |
| rapid influenza tests | 0.533109 |
| outbreak isolate | 0.371021 |
| influenza epidemics | 0.450791 |
| Ardent crew members | 0.51484 |
| Influenza A virus | 0.463483 |
| outbreak information | 0.361849 |
| Base San Diego | 0.340838 |
|
CLICK HERE |
| 13800 |
Centers for Disease Control and Prevention |
Html |
en |
Breast Cancer Screening for Women with Disabilities | Features | CDC |
October is Breast Cancer Awareness Month. All women ages 50 to 74, including women with disabilities, should have a screening mammogram every two years as an important way to lower the risk of dying from breast cancer. |
| common type | 0.45313 |
| disability | 0.462582 |
| New York Department | 0.480417 |
| Health Data | 0.464448 |
| best way | 0.499959 |
| primary care physician | 0.483758 |
| women’s health | 0.564686 |
| health specialist | 0.46771 |
| quality mammogram | 0.521542 |
| cancer-related deaths | 0.454346 |
| health conditions | 0.477757 |
| women ages | 0.49463 |
| NYSDOH Breast | 0.510701 |
| accessible healthcare facilities | 0.480844 |
| health insurance companies | 0.506362 |
| Clinical preventive services | 0.506015 |
| Cancer Early Detection | 0.576545 |
| health promotion materials | 0.498241 |
| inform Oregon women | 0.510332 |
| Montana Women Living | 0.517661 |
| risk no woman | 0.496177 |
| insurance coverage guidelines | 0.484094 |
| U.S Preventive Services | 0.503165 |
| women | 0.621549 |
| Health promotion campaigns | 0.501119 |
|
| area mammography facilities | 0.493194 |
| Public Health | 0.464119 |
| Child Health Programs | 0.499537 |
| United States | 0.453091 |
| self-reported mammography | 0.456156 |
| physical disabilities | 0.533024 |
| limited health literacy | 0.510194 |
| medical clinic | 0.452489 |
| Holy Rosary Healthcare | 0.482824 |
| National Breast | 0.514271 |
| Montana Disability | 0.452595 |
| important way | 0.549873 |
| breast cancer awareness | 0.573237 |
| Regular mammogram screenings | 0.649787 |
| breast cancer screening | 0.767919 |
| Early Detection Program | 0.560436 |
| breast cancer | 0.942406 |
| clinical preventive services.2,3,4 | 0.50028 |
| on-line Montana Mammography | 0.49587 |
| healthcare services | 0.462331 |
| accessible mammography | 0.455383 |
| screening mammogram | 0.603519 |
| Cervical Cancer Early | 0.576908 |
| accessible screening equipment | 0.507233 |
|
CLICK HERE |
| 15893 |
Centers for Disease Control and Prevention |
Html |
en |
Polypharmacy and Health-Related Quality of Life Among USAdults With Arthritis, Medical Expenditure Panel Survey,2010-2012 |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| MEPS prescription medications | 0.305266 |
| poverty status | 0.295206 |
| PCS scores | 0.709941 |
| MCS scores | 0.391954 |
| significantly lower PCS | 0.399223 |
| short-form health survey | 0.288139 |
| federal poverty line | 0.306023 |
| physical component summary | 0.289442 |
| prescription drugs | 0.987506 |
| chronic physical conditions | 0.363259 |
| health care providers | 0.327886 |
| mental component summary | 0.285963 |
| health insurance coverage | 0.354339 |
| health-related quality | 0.39783 |
| fewer drug classes | 0.397609 |
| polypharmacy group | 0.326688 |
| 12-item short-form health | 0.287604 |
| HRQoL measures | 0.345485 |
| rheumatoid arthritis | 0.436628 |
| lower PCS scores | 0.559797 |
| prescription drug classes | 0.325721 |
| multiple prescription medications | 0.292173 |
| arthritis | 0.52711 |
| significantly lower MCS | 0.318773 |
| disease-modifying antirheumatic drugs | 0.325409 |
|
| mean PCS scores | 0.284485 |
| polypharmacy | 0.603038 |
| obstructive pulmonary disease | 0.32234 |
| baseline MCS | 0.33919 |
| adults | 0.47967 |
| anti-inflammatory drugs | 0.285682 |
| polypharmacy groups | 0.321119 |
| prescription medications | 0.314467 |
| retrospective cohort study | 0.299653 |
| early rheumatoid arthritis | 0.298498 |
| prescription drug coverage | 0.451957 |
| low PCS scores | 0.31279 |
| Arthritis Care Res | 0.294781 |
| multiple drugs | 0.303931 |
| explanatory variables | 0.329851 |
| geographic area | 0.283938 |
| chronic conditions | 0.375418 |
| mean MCS scores | 0.289133 |
| lower MCS scores | 0.291609 |
| Health Qual Life | 0.284597 |
| average MCS scores | 0.284691 |
| et al | 0.286712 |
| drug classes | 0.896419 |
| older American Indians | 0.309774 |
|
CLICK HERE |
| 16503 |
Centers for Disease Control and Prevention |
Html |
en |
Guideline Resources: Posters |
null |
| primary care providers | 0.722198 |
| chronic pain | 0.987935 |
| patients | 0.305334 |
| posters | 0.275121 |
|
| Guideline | 0.315883 |
| Prescribing Opioid | 0.59694 |
| information | 0.261202 |
| chronic pain treatment | 0.841919 |
|
CLICK HERE |